https://www.zonebourse.com/cours/action/INNOVENT-BIOLOGICS-INC-49476402/actualite/Innovent-Biologics-Inc-annonce-que-l-etude-clinique-de-phase-3-d-IBI311-a-atteint-le-critere-d--45986363/?utm_source=telegram&utm_medium=social&utm_campaign=share